Compare HCSG & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | ENOV |
|---|---|---|
| Founded | 1976 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | N/A | 2008 |
| Metric | HCSG | ENOV |
|---|---|---|
| Price | $17.49 | $26.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $19.40 | ★ $49.14 |
| AVG Volume (30 Days) | ★ 928.2K | 904.9K |
| Earning Date | 02-11-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | $1,808,303,000.00 | ★ $2,233,266,000.00 |
| Revenue This Year | $9.23 | $9.27 |
| Revenue Next Year | $5.28 | $4.65 |
| P/E Ratio | $32.12 | ★ N/A |
| Revenue Growth | 6.26 | ★ 11.57 |
| 52 Week Low | $9.13 | $25.47 |
| 52 Week High | $20.26 | $49.38 |
| Indicator | HCSG | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 32.41 | 42.26 |
| Support Level | $19.29 | $26.16 |
| Resistance Level | $19.88 | $27.81 |
| Average True Range (ATR) | 0.67 | 1.05 |
| MACD | -0.18 | 0.09 |
| Stochastic Oscillator | 17.82 | 38.52 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.